Publications | Page 38 | Department of Radiology

2022

Li Y, Rusinek H, Butler T, Glodzik L, Pirraglia E, Babich J, et al. Decreased CSF clearance and increased brain amyloid in Alzheimer's disease. Fluids Barriers CNS. 2022;19(1):21.

Das AB, Tranos JA, Zhang J, Wadghiri YZ, Kim SG. Estimation of Contrast Agent Concentration in DCE-MRI Using 2 Flip Angles. Invest Radiol. 2022;57(5):343-351.

Chen D, Zhang C, Parikh N, Merkler AE, Navi BB, Fink ME, et al. Association Between Systemic Amyloidosis and Intracranial Hemorrhage. Stroke. 2022;53(3):e92-e93.

Jansen WJ, Janssen O, Tijms BM, Vos SJ, Ossenkoppele R, Visser PJ, et al. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurol. 2022;79(3):228-243.

2021

Tozlu C, Jamison K, Gu Z, Gauthier SA, Kuceyeski A. Estimated connectivity networks outperform observed connectivity networks when classifying people with multiple sclerosis into disability groups. Neuroimage Clin. 2021;32:102827.

Khosla M, Ngo GH, Jamison K, Kuceyeski A, Sabuncu MR. Cortical response to naturalistic stimuli is largely predictable with deep neural networks. Sci Adv. 2021;7(22).

Cheal SM, Patel M, Yang G, Veach DR, Xu H, Guo H-, et al. Correction to An -Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy. Bioconjug Chem. 2021;32(2):394.

Zun Z, Kapse K, Quistorff J, Andescavage N, Gimovsky AC, Ahmadzia H, et al. Feasibility of QSM in the human placenta. Magn Reson Med. 2021;85(3):1272-1281.

Dean KE, Shen B, Askin G, Schweitzer AD, Shahbazi M, Wang Y, et al. A specific biomarker for amyotrophic lateral sclerosis: Quantitative susceptibility mapping. Clin Imaging. 2021;75:125-130.

Nguyen TD, Weinsaft JW, Kim J. Editorial for "Magnetic Resonance Assessment of Left Ventricular Ejection Fraction at Any Time Post-Infarction for Prediction of Subsequent Events in a Large Multicenter STEMI Registry". J Magn Reson Imaging. 2021.